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Abstract.  We have identified a 25-kD cytosolic yeast 
protein that mediates a late, prefusion step in transport 
of proteins between compartments of the Golgi ap- 
paratus. Activity was followed using the previously de- 
scribed cell free assay for protein transport between 
Golgi compartments as modified to detect late acting 
cytosolic factors (Wattenberg,  B. W., and J.  E.  Roth- 
man.  1986. J.  Biol.  Chem. 263:2208-2213).  In the 
reaction mediated by this protein, transport vesicles 
that have become attached to the target membrane 
during a preincubation are processed in preparation 
for fusion. The ultimate fusion event does not require 
the addition of cytosolic proteins (Balch,  W. E., W. G. 
Dunphy,  W. A. Braell, and J.  E.  Rothman.  1984. 
Cell.  39:525-536).  Although isolated from yeast, this 
protein has activity when assayed with mammalian 
membranes. This protein has been enriched over 150- 
fold from yeast cytosol, albeit not to complete 
homogeneity. The identity of a 25-kD polypeptide as 
the active component was confirmed by raising mono- 
clonal antibodies to it. These antibodies were found to 
specifically inhibit transport activity. Because this is a 
protein operating in prefusion, it has been abbreviated 
POP. 
T 
HE  understanding  of how proteins  are  transported 
between compartments of  the cell has been greatly en- 
hanced by the introduction  of cell free systems that 
measure these processes in assays where individual compo- 
nents can be manipulated and isolated (Blobel and Dobber- 
stein,  1975; Balch et al.,  1984; Gruenberg  and Howell, 
1986; Braell,  1987; Diaz  et al.,  1988; Goda and Pfeffer, 
1988; Baker et al., 1988; Ruohola et al., 1988; Davey et al., 
1985; Becket's et al., 1987). One of  the first assays to be con- 
strutted measuring vesicular transport was for the movement 
of a membrane glycoprotein,  the vesicular stomatitis virus 
(VSV) ~  G protein,  from a cis to a medial compartment of 
the Golgi (Balch et al., 1984). In this assay, transport is mea- 
sured from a "donor" to an ~acceptor" Golgi fraction.  The 
donor  consists  of membranes  derived  from VSV-infected 
cells, using a glycosylation mutant deficient in the addition 
of a distal N-acetylglucosamine (GIcNAc). Acceptor is de- 
rived from uninfected wild-type cells. Donor therefore con- 
tains underglycosylated G protein and acceptor has the lu- 
menal enzyme that adds GIcNAc to that G protein when it 
is transported from donor to acceptor. This transport is there- 
fore conveniently marked by the addition of GlcNAc to G 
protein, which is experimentally accomplished by the mea- 
surement of [3H]GIcNAc incorporation  into G protein  im- 
1. Abbreviations used in this paper: GIcNAC, N-acetylglucosamine;  LCRI, 
low cytosol requiring intermediate; NEM, N-ethylmaleimide;  NSE NEM- 
sensitive factor; POP, protein operating in prefusion; SNAP, soluble NSF 
attachment protein; VSV, vesicular stomatitis virus. 
munoprecipitates. This assay has been used for an extensive 
characterization  of the transport  mechanism. 
Intercompartmental Golgi transport requires energy in the 
form of nucleotide triphosphates, physiological pH, and os- 
molarity, and a number of proteins, both soluble and mem- 
brane associated (Balch et al.,  1984; Balch and Rothman, 
1985; Wattenberg and Rothman, 1986; Block et al., 1988). 
One of these proteins, the NEM sensitive factor (NSF) has 
been isolated (Block et al., 1988) and its gene cloned (Wil- 
son et al., 1989). The cloned gene was shown to have strong 
homology  to  the  yeast  gene  SEC18, whose  product  was 
known by genetic  criteria  to be involved in ER to Golgi 
transport.  The two gene products were found to have func- 
tional homology as well, and it has subsequently been shown 
that NSF participates  in ER to Golgi transport  in a mam- 
malian system (Beckers et al., 1989) and also has a role in 
endocytic fusion (Diaz et al., 1989). This substantiates early 
speculation that the components and mechanisms of trans- 
port vesicle production, targeting, and fusion used in move- 
ment of proteins  through the Golgi would be shared with 
other transport pathways. 
Because donor and acceptor  can be separately  manipu- 
lated in this system, it has been possible to perform a kinetic 
analysis that has defined substeps in the transport  reaction 
(Balch et al., 1984; Wattenberg et al., 1986). These appear 
to correspond to events in the formation, attachment, and fu- 
sion of transport vesicles. In one of these kinetically defined 
subreactions, transport vesicles attach to the acceptor mem- 
brane  to  form a  prefusion  intermediate  termed the  low 
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1986). It was so nanied because the steps leading to the for- 
mation of the LCRI require much higher levels of cytosol 
than the subsequent steps that process the intermediate to 
fuse transport vesicles into the acceptor membrane. This 
phenomenon simply reflects that the factors required for the 
formation of the LCRI are less active in crude cytosol than 
those that are required in the ensuring reactions. A rather 
surprising result of the kinetic analysis of  transport is that the 
process that leads to fusion after vesicle attachment is rela- 
tively slow. This is fortunate from an experimental stand- 
point as it allows the capture of a substantial portion of the 
transported G protein in the LCRI simply by a kinetic trap. 
The reactions that lead to the fusion of transport vesicles can 
then be studied separately from the reactions that form and 
target the vesicles. 
Here we describe how we have used this procedure to de- 
tect, enrich for, and unambiguously identify a 25-kD protein 
that is apparently the only cytosol derived component re- 
quired to complete the transport process after the formation 
of the LCRI. A preliminary characterization of this activity 
has been described using bovine brain cytosol as a starting 
material (Wattenberg and Rothman, 1986).  The results pre- 
sented here are for a protein from the yeast Saccharomyces 
cerevisiae. It has previously been shown that components in 
yeast cytosol can supply the cytosolic needs of mammalian 
Golgi (Dunphy et al., 1986). We have chosen to pursue the 
yeast protein to take advantage of the well developed yeast 
molecular genetics. We have termed this a protein operating 
in prefusion (POP). 
Materials and Methods 
Materials 
Glycerol and  ammonium  sulfate  were of highest available  purity  from 
Bethesda Research Laboratories (Gaithersburg,  MD).  DE-52  was from 
Whatman  Inc.  (Clifton,  NJ).  Creatine  phosphokinase,  Hepes,  propyl- 
agarose and Sephadexes A-25 and G-75 were purchased from Sigma Chemi- 
cal Co.  (St.  Louis,  MO).  YM-10 membranes were from Amicon Corp. 
(Danvers, MA). A prepacked Mono-Q HR 5/5 column was purchased from 
Pharmacia Fine Chemicals (Piscataway,  N J). SDS-PAGE molecular weight 
standards were from Bio-Rad Laboratories (Rockville Center, NY). Pro- 
teins used as gel filtration standards were from Sigma Chemical Co. Yeast 
culture materials were from Difco Laboratories Inc. (Detroit, MI). UDP(6- 
3H)GIcNAc  (26.8  Ci/mmol)  was obtained  from  New  England  Nuclear 
(Boston, MA). ATP and UTP were purchased from Pharmacia Fine Chemi- 
cals.  Ascites fluid containing a  monoclonal antibody to VSV G protein 
(clone 8G5) (Lefrancois and Lyles, 1982) was a gift from Dr. Leo Lefran- 
cois of the Upjohn Company (Kalamazoo, MI).  Polyclonal rabbit anti- 
mouse serum was obtained from Cappel Laboratories (Malvern, PA). All 
other chemicals were of reagent grade and were purchased from commercial 
sources. 
Cells and Culture 
Wild-type CHO-KI cells were from the laboratory of Dr. J. Rothman (Prince- 
ton University) and CHO mutant clone 15B (Gottlieb et al., 1975) was ob- 
tained from Dr. Stuart Kornfeld (Washington University, St. Louis, MO). 
Alternatively, lecl cells (Stanley et al., 1975), a line with a genetically iden- 
tical lesion to 15B ceils were used (American Type Tissue Culture Collec- 
tion, Rockville, MD). Results from the two were indistinguishable. Cells 
were maintained in suspension (wild type) or monolayer culture (15B or 
lecl) in alpha-MEM containing 10%  FCS. Stocks of VSV were grown in 
monolayer BHK cells as described by Balch et al. (1984a).  The infection 
of 15B cells with VSV was done as described in that report as was the prepa- 
ration of homogenates from wild type and VSV-infected 15B cells, the isola- 
tion of Golgi fractions from those homogenates, and the preparation of 
cytosol from either wild-type or mutant cells. The protein content of the 
membrane fractions was generally between 0.5 and 1 mg/ml, and of cytosol 
was "~5 mg/ml. 
The mouse myeloma fusion partner SP2/0 was obtained from Dr.  Ann 
Berger of  the Up  john Company. Hybridoma lines were grown in DME/high 
glucose containing 4 mM glutamine, 100 U/mi penicillin, 100 itg/ml strep- 
tomycin, and 20% FBS. For HAT selection, this medium was supplemented 
with 10 itg/ml hypoxanthine, 400 nM aminopterin, 16 izM thymidine. For 
large scal  e purification of monoclonai antibodies, clonal lines were grown 
to confluency in complete medium, then split 1:2 in DME containing 1% 
Nutridoma-SP (Boehringer, Indianapolis, IN), and allowed to grow for 2 d. 
mAb was then purified from culture supernatants by precipitation with 50 % 
ammonium sulfate and subsequent dialysis against PBS. 
The Assay for Cytosol Components Acting at a Late 
Stage in lntra-Golgi Transport 
This assay is essentially the same as that previously reported (Wanenberg 
and Rothman,  1986).  A  preincubation mix is assembled containing (for 
each tube subsequently to be assayed) 5 #1 of donor membranes, 5 pl of 
acceptor membranes, and 2.5 ~1 of cytosol in a 50-itl volume containing 
25 mM Hepes, pH 7.5, 25 mM KCI, 2.5 mM Mg(C2H302)2,  50 itM ATE 
250  itM  UTP,  2  mM creatine phosphate, and  7.3  U/ml creatine phos- 
phokinase. This mix is incubated for 25 rain at 37°C. This results in the 
formation of a prefusion complex termed the LCRI. Membranes were then 
pelleted at 12,000 g for 3 rain through a cushion of 50 ~tl of 0.3 M sucrose 
in a  1.5-ml microfuge tube (,~600 iti of preincubation/tube). Membranes 
were resuspended in a buffer containing 25 mM Hepes (pH 7.5),  15 mM 
NaCI,  1.5 mM Mg(C2H302)2,  50/~M ATP, 250 itM UTP, 2 mM creatine 
phosphate,  7.3  U/ml creatine phospbokinase, 0.25  M  sucrose, and  2.5 
t~Ci/ml (87 nM) UDP-(3H-GIcNAc). Cytosol fractions were added and in- 
cubations were continued for an additional 90 min. The assay was termi- 
nated by addition of 50 itl of detergent solution containing 50 mM Tris (pH 
7.5),  250 mM NaCI,  1 mM EDTA,  1% Triton X-100 and 1% Na-cholate. 
VSV G protein was precipitated by addition of 0.6 itl 'of monoclonal anti- 
body 8(35 in ascites fluid, and 7 t~l of rabbit anti-mouse serum. After incu- 
bation at 37°C for 15 min the immunoprecipitate was collected by retention 
on type HA, 0.45 #M filters (Millipore Continental Water Systems, Bed- 
ford, MA). After washing, filters were dried and counted using Ready-Safe 
(Beckman Instruments, Inc., Palo Alto, CA). 
"Standard" Transport Assay  for Soluble Components 
Required at All Steps of Transport 
These assays were carried out essentially as previously described (Balch et 
al., 1984a).  Briefly incubations containing 5 #l of  donor and 5 it[ ofacceptor 
were incubated with cytosol in buffer of the same composition as that in the 
first stage of  the assay for POP activity except that [3H]UDP-GicNAc (2.5 itCi/ 
ml) was included. Incubations were terminated  and immunoprecipitated  after 
60 rain of incubation at 37°C. 
Preparation of Yeast Cytosol 
The yeast used for these preparations is UC7558  (a,  leu2,pep4::URA3, 
urn3, gal2,barl,suc2), from the Upjohn collection. The important features 
of this strain are that it is deleted for P¢I  M, a vacuolar protease that activates 
other proteases, and Sue2, invertase, which is inhibitory in this assay be- 
cause of its production of hexoses from sucrose contained in the added 
membrane fractions. This has been shown to deplete the ATP required for 
transport (Dunphy et al.,  1986). 
For small scale preparations,  1.5 liters of yeast were grown in YEPD 
medium (2% bacto-yeast extract, 1% bacto-peptone, 2% glucose) and har- 
vested in late log phase. The cells were pelleted by a 10-min centrifugation 
at  6,000  rpm in a  rotor (GSA;  Sorvall, Wilmington, DE)  for  10  rain, 
resuspended in 10 mM KPO4 pH 7.0, and recentrifuged. This was repeated 
once, the resulting pellets were weighed, and then resuspended in lysis 
buffer (100  mM Hepes, 500 mM KCI, 5 mM MgCI2,  1 t~M pepstatin,  1 
mM  PMSE  1 mM  nametabisulfite,  10  ~g/ml  leupeptin,  0.5  mM  130 
phenanthroline, pH 7.0) at 2 ml of buffer/g of pellet. The resuspended pellet 
was lysed in a Bead Beater (Biospec Products, Bartlesville, OK) using equal 
volumes of yeast suspension and 0.5-mm glass beads with six 20 s bursts 
interspersed  by 30-s cooling periods. All operations were performed at 4°C. 
The lysate was cleared with a low speed centrifugation (26,900 g in an SS34 
rotor, 15 min, Sorvall) and a high speed centrifugation (201,800 g, type 60 
rotor, 60 rain, Beckman Instruments, Inc.). The cleared lysate was then dia- 
lyzed overnight into column buffer (25 mM Hepes, 1 mM MgCI2, pH 7.0). 
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Sephadex G-25 column equilibrated with column buffer. The G-25 column 
was always at least 10-fold greater volume than the load of yeast extract. 
The resulting desaited extract is termed "yeast cytosolY 
For large scale preparations, 250 liter of yeast were grown in YEPD to 
late log or early stationary phase. Densities at harvest were typically 8-14 
OD units. The cell pellet was collected in a centrifuge (Sharpies-Stokes 
Div., Warminster, PA), resuspended in ,x,100 liters of l0 mM KPi (pH 7.0; 
4°C) and repelleted. This pellet was frozen overnight at  -200C.  Pellets 
typically weighed 2-4 kg. The pellet was thawed by agitation in a twofold 
(vol/wt) volume of cold lysis buffer.  The suspension was lysed by passage 
through a glass bead homogenizer (Dynamil) at a rate of 6 liters/h. The ly- 
sate was centrifuged at 5,000 g in a H4000 rotor (Sorvall) for 30 min. The 
resulting cloudy supernatant was concentrated approximately fourfold and 
buffer was exchanged to column buffer using an Amicon Corp. (Danvers, 
MA) DCIOL hollow fiber filter (molecular weight cut off, 10,000).  This ly- 
sate was stored overnight at 40C and then centrifuged for 1 h at 235,000 g 
in a  45Ti  rotor (Beckman Instruments Inc., Palo Alto, CA), yielding a 
somewhat cloudy, reddish supernatant. 
Removal of a Transport Inhibitor by 
A-25 Chromatography 
3.2 liters of cleared lysate were applied to a  10-cm by 40-cm column of 
Sephadex A-25 equilibrated with column buffer at a rate of 4.8 liters/h. The 
column was eluted with column buffer at the same rate, and the major pro- 
tein peak was collected and pooled in a total volume of 4 liters. This mate- 
rial is referred to as yeast cytosol. 
Chromatographic Enrichment of POP 
DEAE Cellulose  Chromatography  of Yeast Cytosol.  4  liters of yeast 
cytosol were applied to a  10-cm  x  20-cm column of DE-52 (equilibrated 
with column buffer), washed with 8 liters of column buffer and eluted with 
a 0-400 mM NaCI gradient (in column buffer) in a total gradient volume 
of 16 liters. Flow rate was 800 ml/h and fractions were 600 ml. 
Propyl-agarose Chromatography. Active fractions from DE-52 chroma- 
tography were pooled. The pool  was then dialyzed extensively against 
2.6 M ammonium sulfate/20% glycerol (vol/vol) in 25 mM Hepes/1 mM 
EDTA, pH 7.0. An inactive protein precipitate was removed by centrifuga- 
tion (30 rain at 70,000 g). A propyl-agarose column of 5 cm by 20 cm was 
equilibrated with the dialysis buffer and half of the pooled fractions were 
loaded. The column was washed with 100 ml of dialysis buffer and then 
eluted with 2.6-1.4 M ammonium sulfate gradient in column buffer contain- 
ing 20% (vol/vol) with glycerol in a gradient volume of 4 liters. Flow rate 
was 400 ml/h and fractions were 50 ml. A portion of each fraction was ex- 
tensively dialyzed against column buffer before each assay utilizing a mul- 
tichannel dialyzing apparatus (Bethesda Research Laboratories). 
Gel  Filtration  Chromatography.  The  active pool  from  hydrophobic 
chromatography was dialyzed against column buffer containing 200 mM 
NaCI and 20% glycerol. This pool was divided in half. Each half was con- 
centrated 'x,15-fold on a YM-IO membrane (Amicon Corp.) and then was 
separately  loaded  onto  a  5-cm  x  88-cm  column  of Sephadex  G-75 
(medium) equilibrated with the same buffer. The load volume was ,x,45 ml. 
The load and elution rate was 100 ml/h. Fractions were 35 ml. The column 
was calibrated with blue dextran (Vo), ovalbumin (44 kD), superoxide dis- 
mutase (35 kD), and cytochrome C  (12.5  kD). 
Mono-Q Ion-Exchange Chromatography. Active fractions from gel filtra- 
tion chromatography were pooled and dialyzed extensively against 25 mM 
Tris/l mM MgCI2, 15% glycerol (vol/vol), pH 8.0. 5.4 ml of this pool was 
loaded onto a Mono-Q column (HR 5/5) at a rate of 0.4 ml/min. This was 
washed with the dialysis buffer (3 ml) and eluted with a gradient of 0-100 
mM NaCI in the dialysis buffer. Total gradient volume was 42 ml, elution 
rate was 0.4 ml/min, and fraction size was  1 ml. 
Gel Electrophoresis, Electrophoretic Transfer, 
lmmunoblotting, and Purification of  p25 from 
Polyacrylamide Gels 
PAGE was carried out essentially according to Laemmli (1970)  where the 
running gel contained 15% acrylamide, using the mini-protean gel system 
(Bio-Rad Laboratories). 
Western blotting.  Proteins separated by SDS-PAGE were electroblotted 
to nitrocellulose membranes at  100 V  for 60 min in a  buffer containing 
14.4 g glycine, 3 g Tris base, and 200 ml methanol/liter. Membranes were 
blocked by incubation in PBS, containing 0.05%  Twcen-20 (PBS +  T) with 
5 % nonfat dry milk for at least 60 min. Hybridoma supernatants or purified 
IgG fractions were diluted in PBS +  T and incubated with blocked mem- 
branes for at least 60 min. Membranes were then washed three times with 
PBS +  T and a 1:1,000 dilution of peroxidase-labeled goat anti-mouse IgG 
(Kirkegaard &  Perry Laboratories, Gaithersburg, MD) in PBS  +  T  was 
added. After a 60-min incubation, membranes were washed three times 
with PBS + T and once with PBS. Peroxidase activity was detected by addi- 
tion of the substrate 4-chloro-l-napthol. 
Gel Purification of  p25. Mono-Q fractions containing p25 as '~10% of 
the total protein were run on 15%  SDS-PAGE. After electrophoresis, the 
gel was briefly stained with Coomassie G-250 (Holbrook and Leaver, 1976) 
until the band pattern was apparent. The band migrating at 25 kD was ex- 
cised with a razor blade and minced into l-mm  2 pieces. Protein was dec_ 
troeluted in 50 mM ammonium bicarbonate at 8 mA for 4 h using an electro- 
elntion device (Mini Protean 1I; Bio-Rad Laboratories) as per manufacturer's 
recommendations. The eluant was concentrated by lyophilization. Protein 
purity and recovery were estimated by rerunning on SDS-PAGE and stain- 
ing with Coomassie blue R-250. 
Determination of  p25 Content in Crude Fractions by 
Densitometry of  lmmunoblots 
The amount of  P25 in a Mono-Q fraction was estimated by densitometric scan- 
ning of a Coomassie blue-stained SDS acrylamide gel using a CS-930 dual 
wave length scanning densitometer (Shimadzu Scientific Instruments Inc., 
Kyoto, Japan). Knowing  the protein concentration  of  the Mono-Q fraction, an 
estimate of  p25 concentration could be made. Mono-Q fractions containing a 
known amount of p25 were then blotted to nitrocellulose and reacted with 
POP1 antibody as described. Staining intensity was determined  by densitom- 
etry and a standard curve prepared. Similar blots of crude DE-52 fractions 
of known protein concentration allowed estimation of p25 content of these 
fractions. 
Production of  Monoclonal Antibodies against p25 
Mouse Immunization and Fusion. Two female CFA-I mice were injected 
subcutaneously with a Mono-Q fraction similar to that shown in Fig. 2, con- 
taining 50 ~tg of protein (5-10 ~tg of p25) in complete Freund's adjuvant. 
Mice were boosted three times at 3-wk intervals with similar 50-/~g subcuta- 
neous injections in incomplete Freund's adjuvant. 2 d before the fusion mice 
were injected intravenously with 5 t~g of pure 1325, as isolated from SDS- 
PAGE.  One mouse was killed, the spleen removed and minced in PBS. 
Spleen cells were isolated and fused to the mouse myeloma fusion partner 
SP2/0 using PEG. Hybridomas were selected by growth in DME medium 
containing HAT. Lines secreting antibodies to p25 were detected by ELISA 
and were cloned through two rounds of limiting dilution. 
ELISA. ELISA plates were prepared by adding 50 ttl of  carbonate buffer, 
pH 9.6, containing 3 ng of gel purified p25 to each well of a 96-well half 
area ELISA plate (Costar, Cambridge, MA) and incubating for 24 h at 4°C. 
Unadsorbed antigen was removed and plates washed three times with PBS 
+  T. Nonspecific binding sites were blocked by addition of 100/~1 of PBS 
+  T containing 0.1% gelatin (Sigma Chemical Co.) for 60 minutes. Wells 
were washed three times with PBS +  T and 50/.d of hybridoma supernatant 
was added. After incubation at room temperature for 60 min, wells were 
washed three times with PB +  T. 50 ttl of a 1:1,000 dilution of HRP-labeled 
goat anti-mouse IgG (Kirkegaard & Perry Laboratories) in PBS +  T was 
added to each well and incubated for 60 rain at room temperature. Wells 
were again washed four times with PBS  +  T, and the peroxidase activity 
was detected using the substrate 2,2'-azino-di(3-ethylbenzthiazoline sul- 
fonate). Reactions were stopped by adding SDS to 2.5% and the color read 
at 405 nm using a multi-scan plate reader (Flow Laboratories, Inc., VA). 
Results 
Initial studies have shown that there is a  specific protein- 
aceous factor in mammalian cytosol that drives a late step 
in the intercompartmental transport of protein through the 
Golgi (Wattenberg and Rothman, 1986), although this factor 
was not identified. In this late step, a prefusion complex con- 
sisting of transport vesicles attached to the acceptor Golgi 
compartment is acted on to fuse the transport vesicles into 
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Figure 1. Activity of yeast and CHO cytosols in the assay for late 
acting transport factors. Yeast (closed circles) and CHO cell (open 
circles)  cytosois  were prepared as  described in  Materials and 




the acceptor. Recently yeast cytosol was found to supply all 
of the required soluble factors for transport to proceed (Dun- 
phy et al.,  1986), presumably including POP. We have pur- 
sued the purification  and  identification of POP in yeast to 
take advantage  of the powerful tools of molecular genetics 
available  in this organism. 
POP activity is measured in a two step assay. In the first 
incubation VSV G protein is driven into the prefusion inter- 
mediate (called the LCRI) by the action of an excess of un- 
fractionated  mammalian cytosol for 25 min at 37°C. Because 
the  ensuing  steps  are  slow,  most  G  protein  is  kinetically 
trapped in the LCRI after 25 min of incubation (Wattenberg 
et al., 1986). The membranes from this incubation are then 
pelleted through a sucrose cushion to remove the unfractio- 
nated cytosol and resuspended with buffer, an ATP regener- 
ating system, [3H]UDP-GIcNAc, and the cytosol fraction to 
be tested for POP activity.  This mixture is then further in- 
cubated for 90 min before immunoprecipitation of G protein 
and  the  determination  of  pH]GIcNAc  incorporation  into 
the immunoprecipitates. 
A comparison of the POP activity  in cytosols derived from 
CHO levels and yeast is shown in Fig. 1. As expected, yeast 
cytosol did indeed contain POP activity.  Surprisingly,  yeast 
and CHO cytosols had comparable levels of activity.  When 
tested in the standard assay, where it must provide the solu- 
ble factors needed for early steps of transport as well as POP, 
yeast  cytosol  is  only  10-20%  as  effective as  mammalian 
cytosol (Dunphy  et al.,  1986). 
Yeast cytosol was fractionated  through  ion exchange, hy- 
dr•phobic, gel filtration, and high performance  ion-exchange 
chromatographies  (Fig.  2).  The  elution  position  of yeast 
POP activity on DEAE-cellulose,  between 30 and 50 mM 
salt, was similar to that previously reported for POP activity 
from calf brain cytosol. In addition gel permeation chroma- 
tography  revealed that POP behaved as a protein of approxi- 
mately 25 kD, also the same as that shown previously for the 
bovine form. A summary of this enrichment procedure when 
performed on a large scale is presented in Table I. In general, 
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Figure 2.  Enrichment of POP through ion exchange, hydrophobic, and gel permeation chromatographies.  Details of the chromatography 
are described in Materials and Methods. In each panel are shown activity in the assay for late acting factors (open circles), protein concentra- 
tion (filled circles), and salt concentration when applicable (dashed lines), a, Ion exchange  chromatography  on DEAE-cellulose. Yeast 
cytosol was fractionated on DE-52. b, Hydrophobic  chromatography  on propyl-agarose.  Active DE-52 fractions  (fractions  24-26) were 
dialyzed in 1.8 M ammonium sulfate,  loaded, and chromatographed  on propyi-agarose,  c, Gel permeation chromatography  on Sephadex 
G-75. Propyl-agarose  fractions 48-68 were dialyzed and loaded onto Sephadex G-75. Molecular mass standards from calibration runs are 
indicated at the top of the panel, d, Ion exchange chromatography on Mono-Q. G-75 fractions 26-32 were dialyzed and applied to Mono-Q 
as described. 
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Specific 
activity 
Total  Recovery of  (cpm//tg, fold 
Volume  protein  Total activity  activity (percentage  enrichment 
Pool  (ml)  (rag)  (cpm)  of A-25)  over A-25) 
A25  4,000  1.5  x  l0  S  3.9  ×  109  100  2.7  x  104 (1) 
DE52  1,600  1.5  ×  10  a  1.4  X  109  36  9.7  x  104 (3.6) 
Propylagarose  182  1310  4.1  ×  l0  s  10  3.1  x  105 (11.5) 
G-75  103  35.0  6.2  x  107  1.6  1.8  ×  106 (67) 
Mono-Q  23  2.1  9.7  x  106  .25  4.7  x  106 (174) 
Shown are the results for pooled fractions resulting from the chromatography steps illustrated  in Fig. 2. After the DE-52 step several identical  smaller pools were 
generated and subject to parallel  purifications as described in Materials and Methods. To estimate the figures shown above, the pool of one representative run 
for each chromatographic step was chosen, and the resulting numbers were multiplied by the number of runs required to completely process the material from 
the preceding step. Frozen pools were titered in a single assay. These figures also reflect  losses due to preparative steps for each column such as dialysis and 
concentration. 
the recovery of activity was quite variable. In pilot studies 
almost quantitative recovery of activity could at times be 
demonstrated at each chromatographic step; however,  this 
was not consistent. The reasons for the variable loss of activ- 
ity are not clear. Because recovery of activity was limited, 
we regard the enrichment of 170-fold over the starting mate- 
rial to be a lower limit for the actual purification of POP, and 
consider it likely that a considerable portion of the purified 
protein in these fractions is inactive. 
When an active pool from the purification procedure was 
re-run over Mono-Q, a further purification was found (Fig. 
3).  When the resulting fractions were analyzed by PAGE 
(Fig. 3, b) a polypeptide of 25 kD (p25) was found to coelute 
with activity (Fig. 3, a). The band at 20 kD corresponds to 
copper/zinc superoxide dismutase as judged by enzymatic 
activity and Western blotting (data not shown). The identity 
of the bands of 15 and 30 kD are unknown. 
To confirm that p25 was responsible for POP activity, we 
developed cell lines producing monoclonal antibodies to the 
protein. Mice were immunized with Mono-Q column frac- 
tions in which p25 constituted from 5-10% of total protein 
(see Materials and Methods). To screen for the desired hy- 
bridomas p25 was purified in a denatured form from SDS 
polyacrylamide gels. This antigen was then used in ELISA 
assays. Five stable lines have been established which pro- 
duce antibodies reactive against p25.  All five lines produce 
antibodies of the subclass IgG1. One of these, POP1, is fur- 
ther characterized below. 
POP1 was used to probe for p25 in immunoblots. Shown 
in Fig. 4 is a Western blot using POP1  to stain a Mono-Q 
fraction (lane 5), a relatively crude yeast fraction from DE- 
52 chromatography of yeast cytosol (lane 6), and cytosols 
derived from bovine brain and CHO cells (lanes 7 and 8). 
POP1 strongly and specifically recognizes a protein of  25 kD 
in both crude and purified yeast fractions. No other proteins 
are bound by this antibody in the yeast fractions. There is 
no reaction against either mammalian cytosol. When p25 
was measured in cytosol and Mono-Q fractions by quantita- 
ting immunoblots densitometrically (see Materials and Meth- 
ods), it was determined that p25 constitutes '~.008% of the 
protein in the DE-52 fraction. 
The correlation between POP activity and p25 was tested 
by preincubating cytosol fractions with antibody and testing 
for transport activity. A relatively crude cytosol fraction, the 
pool  resulting  from DE-52  chromatography,  was  treated 
with either control IgG1 or POP1 antibodies for 4 h at 37°C. 
The activity of these fractions, as well as a fraction without 
any added antibody, is shown in Fig. 5 A. The 37°C incuba- 
tion itself only slightly decreased the activity of this fraction 
(data not shown). Preincubation of the fraction with POP1 
resulted in a profound inhibition of activity whereas the con- 
trol antibody had only a slight effect. The level of inhibition 
by POP1 was ",,80% when compared to the control antibody. 
The  remaining activity plateaued at  low  levels  of added 
cytosol, and did not increase with additional added protein. 
The reason for this behavior is not clear. Inhibition of activ- 
ity occurred with 4°C pretreatment of cytosol fractions with 
antibody; however, the inhibition was not as complete (data 
not shown.) 
POP1 only very weakly immunoprecipitates p25 (data not 
shown). This is not uncommon for monoclonal antibodies 
and presumably accounts for the relatively high amounts of 
antibody required to inactivate POP activity. To rule out the 
possibility that the observed inhibition was because of a non- 
specific effect of this particular antibody preparation on the 
cytosol fraction or on the assay itself, the antibodies were 
preincubated with cytosol from CliO cells. The immunoblot 
depicted in Fig. 4  indicates that POP1  will not react with 
mammalian POP.  This preincubation had no effect on the 
POP activity of CliO cytosol (Fig. 5 b.) Therefore, the inhi- 
bition we observed by POP1  on yeast cytosol is a specific 
effect of the interaction of antibody with p25. 
Although there is considerable indirect evidence that the 
LCRI is a transport intermediate, this has not been directly 
shown. To substantiate that POP participates in the transport 
reaction as a whole, antibody-treated cytosol fractions were 
tested in the standard transport assay,  which requires the 
components involved in early as well as late substeps (Fig. 
6). In contrast to ion-exchange fractionations of mammalian 
cytosol (Wattenberg and Rothman,  1986),  the DE-52 pool 
from yeast cytosol contains all required transport factors. 
When this fraction is treated with POP1, the standard activ- 
ity is clearly reduced, although not as strongly as activity 
measured in the assay for POP activity (Fig. 5). This was not 
unexpected as the standard activity of yeast cytosol is low 
when compared to CHO cytosol (Dunphy et al.,  1986, and 
Fig. 6). Since POP activity of yeast and CliO cytosols are 
similar (Fig.  1), the ratio of the activity of factors required 
Wattenberg et al. A 25-kD Prefusion Protein from  Yeast  951 Figure 3. A25-kD protein co-purifies with POP activity on rechro- 
matography of  Mono-Q fractions. Active fractions from a Mono-Q 
fractionation (66 #g in 3 ml) similar to that shown in Fig. 2, d, were 
pooled and dialyzed into 25 mM Tris/l  mM EDTA/15% glycerol 
(pH 8.0), and then rechromatographed on Mono-Q under the same 
conditions as originally used. Protein content was too low to be ac- 
curately measured, a, Transport activity, b, PAGE  (15 % acylamide) 
of fractions  from Mono-Q  fractionation.  Shown are the fraction 
loaded onto the column  (Load,  10 #1), and samples of fractions 
from the column (25 #l/lane) stained with Coomassie blue. At right 
are indicated the migration of molecular mass standards. The posi- 
tion of p25 is indicated by an arrowhead. 
no immunoreactive proteins. This substantiates POP1  is in- 
hibiting by a specific interaction with the active component. 
A preliminary characterization of POP activity from bo- 
vine brain cytosol (Wattenberg and Rothman, 1986) demon- 
strated  that  the  mammalian  protein  elutes  from  DEAE- 
cellulose at •30-50  mM salt and sizes as a globular protein 
of 25 kD. These characteristics are very closely matched by 
yeast POP. This physical similarity should not be surprising 
as the two sources yield functionally homologous activities. 
However, this homology is not so exact that there is a strong 
cross reaction with the monoclonal antibody used here. The 
production of a polyclonal serum using pure POP may reveal 
more of the  structural  similarity between yeast and mam- 
malian POP. 
The variability in recovery of activity during the manipula- 
tion of yeast POP is of concern and interest.  The intrinsic 
stability of the protein seems high. Loss of activity is mini- 
mal even with incubation at 37°C for several hours in crude 
fractions or for several days at 4°C in both crude and purified 
preparations (data not shown). One possibility is that there 
is a second protein component being supplied by the yeast 
cytosol which is required in the consumption of the LCRI. 
We consider this unlikely since each chromatographic step 
has  resulted  in  quantitative  recovery during  pilot studies. 
However, until we can test the transport activity of homoge- 
neous POP this explanation cannot be entirely excluded. Al- 
ternatively, there may be a small molecular weight cofactor 
bound to POP that is released if the protein is slightly dena- 
tured (for instance,  by interaction with a chromatographic 
matrix). 
The only other protein which has been isolated using the 
cell free transport assay is the NSF. This is an ATP binding 
protein that appears to cycle on and off the Golgi membranes 
(Glick and Rothman, 1987).  The attachment of NSF to the 
in early steps to POP activity is low when assayed in the bet- 
erologous  mammalian  system.  Therefore,  only  a  minor 
amount  of  POP  activity  is  required  to  complement  the 
limited levels of early factors. 
Discussion 
We have identified a 25-kD yeast protein (POP) that acts in 
a  late prefusion step of vesicular transport between Golgi 
compartments. The yeast activity was assayed in a heterolo- 
gous system using Golgi membranes prepared from CHO 
cells. Although we do not as yet have a homogeneous prepa- 
ration of this protein,  monoclonal antibody technology al- 
lowed us to make an unambiguous identification of the pro- 
tein responsible for POP activity. The antibody (designated 
POP1) recognizes only a single 25-kD band on immunoblots 
of yeast cytosol fractions.  It inhibited  the  late activity of 
yeast cytosol fractions when preincubated with them, but did 
not inhibit the activity of CHO cytosol, in which there are 
Figure 4. Characterization of anti-p25 monoclonal antibody POPI 
by immunobiotting.  Gel  electrophoresis  was carried  out  as  de- 
scribed in Materials and Methods on CHO cell cytosol (lanes I and 
8, t00 #g), bovine brain cytosol (lanes 2 and 7, 100 #g), an active 
pool from DE-52 chromatography of yeast cytosol (lanes 3 and 6, 
70 #g), and a p25 enriched Mono-Q fraction (lane 4, 5 #g, and lane 
5,  1 #g).  Lanes 1-4, protein staining with fast green.  Lanes 5-8, 
immunoblotting with antibody POP1 using a  1:30 dilution of cell 
culture supernatant. 
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Figure 5. Monoclonal antibody POPI  inhibits trans- 
port activity of yeast but not CHO cytosol.  To 50/~1 
of cytosol was added 7.5 #1 (32 #g) of either POPI or 
B-I (a control IgG, monoclonal directed against IL-lfl), 
or 7.5 IA of PBS. The cytosol was then incubated for 
4 h at 37°C, centrifuged for 3 min at 12,000 rpm, and 
the supernatant was titered for activity in the assay for 
late acting factors. In the absence of added antibody, 
both yeast and CHO cytosols were only slightly af- 
fected by the incubation at 37°C when compared to 
controls held on ice (not shown), a, Treatment of a 
pool resulting from DE-52 chromatography  of yeast 
cytosol (9.2 mg/ml protein).  PBS control (filled cir- 
cles); anti-p25 POP1 (open circles); control antibody 
B-1  (closed  triangles),  b,  Treatment  of CHO  cell 
cytosol  (9  mg/ml protein).  PBS control  (filled cir- 
cles); anti-p25 POP1 (open circles). 
membrane is mediated by a  soluble  factor termed SNAP 
(soluble NSF binding protein; Weidman et al.,  1989).  Ki- 
netic and morphological studies (Malhotra et al., 1988; Orci 
et al.,  1989)  indicate that NSF acts after coated transport 
vesicles attach to the acceptor membranes and lose their coat 
protein, but before the formation of the LCRI. Therefore, 
POP comes into play after the interaction of NSF with the 
acceptor membranes. 
As the only cytosolic protein apparently required  at the 
last stages of transport, it is possible that POP is itself a fuso- 
gen. However, previous studies have shown that the final fu- 
sion event proceeds in the absence of added cytosolic factors 
(Balch et al.,  1984b). If POP is a fusogen, it must attach to 
the membrane and become activated before the fusion event 
itself occurs. Preliminary data on the action of POP indicates 
that it must be continuously present during the consumption 
of the LCRI and that it is not depleted from cytosol during 
the transport reaction (data not shown).  So its action must 
be brief and it apparently can act catalytically. The amount 
of POP required to drive the reaction can be calculated from 
the abundance of POP in the DE-52 pool (0.008%), the pro- 
tein content of that pool (9.2 mg/ml) and the amount of the 
pool that saturates the assay (5/xl in a 50/zl assay). This indi- 
cates that only 74 ng/ml, ~3 nmol, will sustain the reaction. 
This low level is also consistent with a catalytic action of the 
protein. 
Rothman has suggested that POP is part of a transient fu- 
sion complex that includes NSF and SNAP (Wilson et al., 
1989).  The amount of POP required in the assay, as calcu- 
lated  above,  is  significantly  below  that  of purified  NSF 
(Weidman et al.,  1989).  However, this comparison is be- 
tween purified NSF, which may be substantially reduced in 
activity, and POP in a crude fraction. The abundance of NSF 
has been calculated to be between 0.2 and 0.02% of mam- 
malian cytosolic protein. This within an order of magnitude 
of the abundance of POP. There is as yet no experimental evi- 
dence for a direct interaction between NSF/SNAP and POP. 
However, this remains an intriguing possibility. 
It is particularly interesting that the events that lead up to 
fusion after the attachment of the transport vesicles are so 
lengthy in this system. This stands in contrast to the fusion 
of secretory vesicles at the cell surface where exocytosis can 
be extremely rapid once the excitatory signal has been trans- 
duced (for review, see Tartakoff, 1987). To what extent the 
kinetics of transport have been altered in this in vitro system 
remains to be established.  However, the Golgi system may 
have evolved to limit fusion to defined regions of the cister- 
nae and/or to prevent fusion of vesicles that have been incor- 
rectly targeted. In the Golgi it may be more of a problem to 
control fusion than to initiate it. In this context POP may act 
to direct transport vesicles to sites of fusion as previously 
suggested (Wattenberg and Rothman,  1986),  or to unmask 
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Figure 6. Yeast cytosol treated to inhibit POP activity is diminished 
in total transport activity. A yeast DE-52 pool was treated with ei- 
ther POP1 antibody or control antibody B-I as described in the leg- 
end to Fig. 5. These cytosols were then titered in the standard assay 
which requires  the activity of factors acting early in the transport 
assay as well as those acting at late steps. For comparison, the activ- 
ity of CHO cytosol is also shown, note the large difference in activ- 
ity between  the CHO (open  triangles,  right ordinate)  and yeast 
cytosols (left ordinate).  Yeast DE-52 pool treated with control anti- 
body B-1  (open  circles);  yeast  DE-52  pool  treated  with  POPI 
(closed circles). 
sites of fusion on the acceptor membrane in response to the 
arrival  of  transport  vesicles  that  have  passed  a  test  of 
legitimacy. 
The promise of a molecular analysis of vesicular transport 
in the cell is in the process of becoming realized.  Now that 
POP  has  been  identified  and  monoclonal antibodies  have 
been produced against it we can begin a detailed analysis of 
how it acts to promote fusion,  how it interacts  with other 
known constituents, and what other components are involved 
in protein transport. 
The identification of POP activity in yeast cytosol and a preliminary frac- 
tionation of yeast cytosol was performed while B. Wattenberg was in the 
laboratory of Dr. J. E. Rothman, Stanford University, Department of Bio- 
chemistry. Dr. Rothman also contributed helpful suggestions  on the manu- 
script. Ann Berge  r and Darryl Chapman  of this unit were ceaselessly gener- 
ous in donating time and advice in the production of monoclonal antibodies 
against p25.  Members of Unit 1400 of the Upjohn Company performed 
large scale growth of yeast and the processing of the yeast to produce a 
yeast lysate. We thank Dr. Phil Yeagle for discussions  suggesting  that lim- 
iting a fusion process may be an important aspect of vesicle delivery. Drs. 
Karen Leach and Rita Huff provided valuable critical reading of the manu- 
script as well as advice and discussion during the work itself. Debra Piper 
prepared the manuscript with patience and care. 
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